Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?

Trifirò, Gianluca; Crisafulli, Salvatore; Andò, Giuseppe; Racagni, Giorgio; Drago, Filippo

Trifirò, Gianluca; Crisafulli, Salvatore; Andò, Giuseppe; Racagni, Giorgio; Drago, Filippo.

Trifirò G; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy. trifirog@unime.it.
Crisafulli S; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Andò G; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Racagni G; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Drago F; Department of Biomedical and Biotechnological Sciences, Clinical Pharmacology Unit of the University Hospital, University of Catania, Catania, Italy.

Drug Saf ; 43(6): 507-509, 2020 06.

Article in English | MEDLINE | ID: covidwho-72301

Subject(s)

Coronavirus; Diabetes Mellitus; Hypertension; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Betacoronavirus; COVID-19; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; Prognosis; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronavirus / Diabetes Mellitus / Hypertension Type of study: Prognostic study Limits: Humans Language: English Journal: Drug Saf Journal subject: Drug Therapy / Toxicology Year: 2020 Document Type: Article Affiliation country: S40264-020-00935-2

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google